You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 36 No. 5, May 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CSF Viral Antibodies

Evaluation in Amyotrophic Lateral Sclerosis and Late-Onset Postpoliomyelitis Progressive Muscular Atrophy

Jerome E. Kurent, MD; Benjamin Rix Brooks, MD; David L. Madden, DVM, PhD; John L. Sever, MD, PhD; W. King Engel, MD

Arch Neurol. 1979;36(5):269-273.


Abstract

• Serum and CSF from 48 patients with amyotrophic lateral sclerosis and six patients with late-onset postpoliomyelitis progressive muscular atrophy were investigated for the presence of antibody to poliovirus types 1, 2, and 3, coxsackie viruses B3 and B4, influenza A, measles, rubella, mumps, herpes simplex types 1 and 2, cytomegalovirus, varicella-zoster, and Toxoplasma gondii. These results were compared with those from 53 control patients with neuromuscular disease matched for age, sex, race, and poliovirus vaccine exposure. There was no difference either in the distribution of serum or CSF antibody titers or the geometricmean antibody titers. There was no evidence suggesting the presence of locally produced specific viral antibody within the CNS to any of the agents studied. In particular, there was no serological evidence to suggest an association between persistent infection with any poliovirus type and amyotrophic lateral sclerosis or late-onset postpoliomyelitis progressive muscular atrophy.



Author Affiliations

From the Infectious Diseases Branch (Drs Kurent, Madden, and Sever), and the Medical Neurology Branch (Drs Brooks and Engel), National Institute of Neurological and Communicative Disorders and Stroke, and the Department of Neurology (Drs Kurent and Brooks), Johns Hopkins University School of Medicine, Bethesda, Md.


Footnotes

Accepted for publication Aug 28, 1978.

Presented in part at the American Academy of Neurology, Los Angeles, April 27, 1978.

Reprint requests to Medical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bldg 10, Rm 10D18, Bethesda, MD 20014 (Dr Engel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS
Berger et al.
Neurology 2000;54:20-20.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.